|
Characteristics
|
All patients n = 33
|
|---|
|
Sex (men/women), n (%)
|
20 (60.6)/13 (39.4)
|
|
Age (years)*
|
43.2 ± 17.4
|
|
Disease duration (years)*
|
7.0 ± 5.7
|
|
Modified Truelove and Witts severity index*
|
9.4 ± 3.2
|
|
Mayo score (endoscopy)*
|
2.8 ± 0.4
|
|
Extent of disease
| |
|
Left-side type, n (%)
|
13 (39.4)
|
|
Extensive colitis, n (%)
|
20 (60.6)
|
|
Concomitant medications
| |
|
5-ASA formulation, n (%)
|
29 (87.9)
|
|
Corcicosteroids, n (%)
|
11 (33.3)
|
|
Azathioprine/Mercaptopurine, n (%)
|
16 (48.5)
|
|
Tacrolimus, n (%)
|
13 (39.4)
|
|
Cytomegalovirus, n (%)
|
11 (33.3)
|
-
IFX: infliximab, 5-ASA: 5-aminosalicylic acid.
- Results reported as number (%) of patients or as *mean ± standard deviation.
